Sarepta Therapeutics, Inc. (SRPT)

Sarepta Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,829	2,255	11,614	9,021	11,375	7,841
Market Cap Growth	-83.02%	-80.58%	28.75%	-20.70%	45.06%	-41.72%
Enterprise Value	1,929	2,664	11,831	8,677	10,907	7,420
Last Close Price	17.45	21.52	121.59	96.43	129.58	90.05
PE Ratio	-	-	49.37	-	-	-
Forward PE	5.37	90.12	15.47	-	-	-
PS Ratio	0.83	1.03	6.11	7.26	12.19	11.17
PB Ratio	1.61	1.98	7.60	10.50	29.55	8.45
P/TBV Ratio	1.60	1.98	7.74	10.87	30.14	8.58
EV/Sales Ratio	0.88	1.21	6.22	6.98	11.69	10.57
EV/EBITDA Ratio	-	-	46.25	-	-	-
EV/EBIT Ratio	-	-	54.25	-	-	-
Debt / Equity Ratio	0.91	0.91	0.88	1.61	4.20	1.23
Debt / EBITDA Ratio	-	-	3.74	-	-	-
Net Debt / Equity Ratio	0.09	0.09	-0.01	-0.35	-0.97	-1.05
Net Debt / EBITDA Ratio	-0.16	-0.16	-0.05	1.33	0.75	2.41
Net Debt / FCF Ratio	-	-	0.04	0.52	1.04	2.03
Asset Turnover	0.60	0.60	0.53	0.39	0.30	0.23
Inventory Turnover	2.84	2.84	2.10	3.90	5.21	4.12
Quick Ratio	1.22	1.22	2.74	3.23	3.63	5.05
Current Ratio	2.32	2.32	4.20	3.95	4.13	5.75
Return on Equity (ROE)	-53.47%	-53.47%	19.71%	-86.15%	-107.16%	-49.57%
Return on Assets (ROA)	-11.24%	-11.24%	3.77%	-5.24%	-10.68%	-9.04%
Return on Invested Capital (ROIC)	-44.29%	-47.73%	18.93%	-93.16%	-	-
Return on Capital Employed (ROCE)	-29.20%	-29.20%	6.70%	-10.30%	-21.40%	-16.50%
Earnings Yield	-39.02%	-31.64%	2.02%	-5.94%	-6.19%	-5.34%
FCF Yield	-	-	-2.95%	-6.40%	-3.13%	-6.14%
Buyback Yield / Dilution	7.19%	7.19%	-16.75%	-5.53%	-7.75%	-4.24%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q